Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 23/09/19971 min de leitura
Revised Precautionary Measures to Reduce the Possible Transmission of Creutzfeldt-Jakob Disease (CJD) by Blood and Blood Products; Guidance Document; Availability
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing the availability of a guidance document entitled ``Revised Precautionary Measures to Reduce the Possible Transmission of Creutzfeldt-Jakob Disease (CJD) by Blood and Blood Products,'' dated December 11, 1996. The guidance document is intended to provide recommendations to the blood industry and may include information useful to other interested persons.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →